Synovial Hypoxia as a Cause of Tendon Rupture in Rheumatoid Arthritis

Journal of Hand Surgery

Volumn 33, Issue 1, 2008, Pages 49-58

  Sivakumar, Branavan ^a   Akhavani, Mohammed A ^a   Winlove, C Peter ^a   Taylor, Peter C ^a   Paleolog, Ewa M ^a   Kang, Norbert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Arthritis; hypoxia; rheumatoid; rupture synovium; tendon

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HAND SURGERY; HUMAN; HYPOXIA; MALE; MICROELECTRODE; OXIMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; TENDON RUPTURE; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; SYNOVIAL MEMBRANE; TENDINOPATHY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38849135497     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2007.09.002     Document Type: Article

References (38)

1. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 21 (2003) S71-S74
2. Ferlic D.C. Rheumatoid flexor tenosynovitis and rupture. Hand Clin 12 (1996) 561-572
3. Williamson S.C., and Feldon P. Extensor tendon ruptures in rheumatoid arthritis. Hand Clin 11 (1995) 449-459
4. Brown F.E., and Brown M.L. Long-term results after tenosynovectomy to treat the rheumatoid hand. J Hand Surg 13A (1988) 704-708
5. Ertel A.N. Flexor tendon ruptures in rheumatoid arthritis. Hand Clin 5 (1989) 177-190
6. Sivakumar B., Harry L.E., and Paleolog E.M. Modulating angiogenesis: more vs less. JAMA 292 (2004) 972-977
7. Etherington P.J., Winlove P., Taylor P., Paleolog E., and Miotla J.M. VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis. Clin Exp Rheumatol 20 (2002) 799-805
8. Ceponis A., Konttinen Y.T., Imai S., Tamulaitiene M., Li T.F., Xu J.W., et al. Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol 37 (1998) 170-178
9. Walsh D.A., Wade M., Mapp P.I., and Blake D.R. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 152 (1998) 691-702
10. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 13 (1970) 769-776
11. Ahlqvist J. A hypothesis on the pathogenesis of rheumatoid and other non-specific synovitides. IV A. The possible intermediate role of local hypoxia and metabolic alterations. Med Hypotheses 13 (1984) 257-302
12. Treuhaft P.S., and McCarty D. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 14 (1971) 475-484
13. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107 (2001) 1-3
14. Gaber T., Dziurla R., Tripmacher R., Burmester G.R., and Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2!. See what HIF can do!. Ann Rheum Dis 64 (2005) 971-980
15. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180 (1994) 341-346
16. Koch A.E., Harlow L.A., Haines G.K., Amento E.P., Unemori E.N., Wong W.L., et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152 (1994) 4149-4156
17. Nagashima M., Yoshino S., Ishiwata T., and Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22 (1995) 1624-1630
18. Paleolog E.M., Young S., Stark A.C., McCloskey R.V., Feldmann M., and Maini R.N. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41 (1998) 1258-1265
19. Jain A., Kiriakidis S., Brennan F., Sandison A., Paleolog E., and Nanchahal J. Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors. Clin Orthop Relat Res 446 (2006) 268-277
20. Jackson J.R., Minton J.A., Ho M.L., Wei N., and Winkler J.D. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin-1 beta. J Rheumatol 24 (1997) 1253-1259
21. Berse B., Hunt J.A., Diegel R.J., Morganelli P., Yeo K., Brown F., et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115 (1999) 176-182
22. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., and El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46 (2002) 2587-2597
23. Hollander A.P., Corke K.P., Freemont A.J., and Lewis C.E. Expression of hypoxia-inducible factor-1 alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44 (2001) 1540-1544
24. Giatromanolaki A., Sivridis E., Maltezos E., Athanassou N., Papazoglou D., Gatter K.C., et al. Upregulated hypoxia inducible factor-1 alpha and -2 alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 5 (2003) R193-R201
25. Peters C.L., Morris C.J., Mapp P.I., Blake D.R., Lewis C.E., and Winrow V.R. The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 50 (2004) 291-296
26. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1 alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
27. Jain A., Nanchahal J., Troeberg L., Green P., and Brennan F. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum 44 (2001) 1754-1760
28. Jain A., Brennan F., Troeberg L., and Nanchahal J. The role of matrix metalloproteinases in rheumatoid tendon disease. J Hand Surg 27A (2002) 1059-1064
29. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
30. Brennan F.M., Chantry D., Jackson A., Maini R., and Feldmann M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2 (1989) 244-247
31. Brennan F.M., Chantry D., Jackson A.M., Maini R.N., and Feldmann M. Cytokine production in culture by cells isolated from the synovial membrane. J Autoimmun 2 Suppl (1989) 177-186
32. Ikeda M., Hosoda Y., Hirose S., Okada Y., and Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol 191 (2000) 426-433
33. Ballara S., Taylor P.C., Reusch P., Marme D., Feldmann M., Maini R.N., et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 44 (2001) 2055-2064
34. Lewis A.J., and Manning A.M. New targets for anti-inflammatory drugs. Curr Opin Chem Biol 3 (1999) 489-494
35. Safronova O., Nakahama K., Onodera M., Muneta T., and Morita I. Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by Interleukin-1 beta in human synovial fibroblasts. Inflamm Res 52 (2003) 480-486
36. Bodamyali T., Stevens C.R., Billingham M.E., Ohta S., and Blake D.R. Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis 57 (1998) 703-710
37. Taylor P.C., and Sivakumar B. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17 (2005) 293-298
38. Belozerov V.E., and Van Meir E.G. Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs 16 (2005) 901-909